|Day Low/High||81.64 / 82.47|
|52 Wk Low/High||61.40 / 89.93|
Once the safest stocks in the book, the big-cap drug companies are now toxic.
Straying from these names could land you in quicksand as the 4th quarter begins.
For most of this year the market has been led by growth stocks.
BAX declined recently to break the rising 50-day moving average line.
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
The crash of oil will only accelerate the move.
I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.
It is incredibly healthy to see so many stocks so strong, from so many sectors.
It's a wonder to me how split this market really is.
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Their overseas business has been carrying them.
We know that we are in the era when index managers are ascendant.
Five names to consider from my 'stocks for the defensive investor' screen.
Recent upside breakout refreshes bull trend.
There are nearly too many surging sectors to count.
Baxter buys generic drug maker Claris Injectables in a deal that will be accretive to earnings.
Companies that marked turnarounds -- for better or worse -- last week.
But several airline and retail stocks are proving highly volatile.
Check out the names that are showing technical characteristics of bullish or bearish reversal patterns over the last week.
The stock hasn't done anything wrong, but we need to be ready just in case.
The longer-term push is starting to lose steam and may need more consolidation than just a light-volume selloff.